4//SEC Filing
MEI Pharma, Inc. 4
Accession 0001209191-16-136047
$LITSCIK 0001262104operating
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 2:47 PM ET
Size
5.7 KB
Accession
0001209191-16-136047
Insider Transaction Report
Form 4
MEI Pharma, Inc.MEIP
Mass Robert D.
Chief Medical Officer
Transactions
- Award
Restricted stock units
2016-08-05+51,370→ 51,370 total→ Common Stock par value $0.00000002 (51,370 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the registrant's Common Stock.
- [F2]Each restricted stock unit becomes 100% vested on August 5, 2018. Settlement of vested restricted stock units, in shares of Common Stock, shall occur within 5 days of vesting.
Documents
Issuer
MEI Pharma, Inc.
CIK 0001262104
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001262104
Filing Metadata
- Form type
- 4
- Filed
- Aug 8, 8:00 PM ET
- Accepted
- Aug 9, 2:47 PM ET
- Size
- 5.7 KB